Brunner J, Schvartz D, Gouiller A, Hainard A, Borchard G
Biochem Biophys Rep. 2022; 32:101375.
PMID: 36324528
PMC: 9618981.
DOI: 10.1016/j.bbrep.2022.101375.
de Freitas B, Hosch N, Pereira L, Barbosa T, Picolo G, Cury Y
Toxins (Basel). 2021; 13(12).
PMID: 34941749
PMC: 8709465.
DOI: 10.3390/toxins13120912.
Genovese I, Carinci M, Modesti L, Aguiari G, Pinton P, Giorgi C
Int J Mol Sci. 2021; 22(9).
PMID: 33946271
PMC: 8124268.
DOI: 10.3390/ijms22094770.
Yeo M, Kim J, Seong I, Kim J, Kim K
J Cancer. 2017; 8(16):3371-3377.
PMID: 29158810
PMC: 5665054.
DOI: 10.7150/jca.20983.
Tejeda-Munoz N, Gonzalez-Aguilar H, Santoyo-Ramos P, Castaneda-Patlan M, Robles-Flores M
Mol Cell Biol. 2015; 36(5):731-41.
PMID: 26711256
PMC: 4760212.
DOI: 10.1128/MCB.00828-15.
Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastoma.
Kusne Y, Carrera-Silva E, Perry A, Rushing E, Mandell E, Dietrich J
Sci Signal. 2014; 7(338):ra75.
PMID: 25118327
PMC: 4486020.
DOI: 10.1126/scisignal.2005196.
Peripheral sensitization increases opioid receptor expression and activation by crotalphine in rats.
Zambelli V, Fernandes A, Gutierrez V, Ferreira J, Parada C, Mochly-Rosen D
PLoS One. 2014; 9(3):e90576.
PMID: 24594607
PMC: 3942445.
DOI: 10.1371/journal.pone.0090576.
Immunolocalization of Protein Kinase C Isoenzymes α, βI, βII and γ in Adult and Developing Rat Kidney.
Kim W, Lee G, Kim Y, Park E, Hwang J, Kim H
Electrolyte Blood Press. 2014; 5(2):75-88.
PMID: 24459505
PMC: 3894519.
DOI: 10.5049/EBP.2007.5.2.75.
Chemoresistance and Cancer-Related Inflammation: Two Hallmarks of Cancer Connected by an Atypical Link, PKCζ.
Rimessi A, Patergnani S, Ioannidi E, Pinton P
Front Oncol. 2013; 3:232.
PMID: 24062985
PMC: 3770915.
DOI: 10.3389/fonc.2013.00232.
Partitioning-defective protein 6 (Par-6) activates atypical protein kinase C (aPKC) by pseudosubstrate displacement.
Graybill C, Wee B, Atwood S, Prehoda K
J Biol Chem. 2012; 287(25):21003-11.
PMID: 22544755
PMC: 3375524.
DOI: 10.1074/jbc.M112.360495.
The atypical PKCs in inflammation: NF-κB and beyond.
Diaz-Meco M, Moscat J
Immunol Rev. 2012; 246(1):154-67.
PMID: 22435553
PMC: 3531713.
DOI: 10.1111/j.1600-065X.2012.01093.x.
The selective inhibition of nuclear PKCζ restores the effectiveness of chemotherapeutic agents in chemoresistant cells.
Rimessi A, Zecchini E, Siviero R, Giorgi C, Leo S, Rizzuto R
Cell Cycle. 2012; 11(5):1040-8.
PMID: 22333579
PMC: 3323800.
DOI: 10.4161/cc.11.5.19520.
Activation of protein kinase C-ζ in pancreatic β-cells in vivo improves glucose tolerance and induces β-cell expansion via mTOR activation.
Velazquez-Garcia S, Valle S, Rosa T, Takane K, Demirci C, Alvarez-Perez J
Diabetes. 2011; 60(10):2546-59.
PMID: 21911744
PMC: 3178296.
DOI: 10.2337/db10-1783.
Par6B and atypical PKC regulate mitotic spindle orientation during epithelial morphogenesis.
Durgan J, Kaji N, Jin D, Hall A
J Biol Chem. 2011; 286(14):12461-74.
PMID: 21300793
PMC: 3069449.
DOI: 10.1074/jbc.M110.174235.
Protein kinase Czeta regulates Cdk5/p25 signaling during myogenesis.
de Thonel A, Ferraris S, Pallari H, Imanishi S, Kochin V, Hosokawa T
Mol Biol Cell. 2010; 21(8):1423-34.
PMID: 20200223
PMC: 2854099.
DOI: 10.1091/mbc.e09-10-0847.
Interplay between REST and nucleolin transcription factors: a key mechanism in the overexpression of genes upon increased phosphorylation.
Tediose T, Kolev M, Sivasankar B, Brennan P, Morgan B, Donev R
Nucleic Acids Res. 2010; 38(9):2799-812.
PMID: 20100803
PMC: 2875004.
DOI: 10.1093/nar/gkq013.
The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts.
Chamoux E, Couture J, Bisson M, Morissette J, Brown J, Roux S
Mol Endocrinol. 2009; 23(10):1668-80.
PMID: 19589897
PMC: 5224938.
DOI: 10.1210/me.2009-0066.
Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis.
Xie Z, Dong Y, Zhang J, Scholz R, Neumann D, Zou M
Mol Cell Biol. 2009; 29(13):3582-96.
PMID: 19414597
PMC: 2698771.
DOI: 10.1128/MCB.01417-08.
Protein kinase Czeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo.
Galvez A, Duran A, Linares J, Pathrose P, Castilla E, Abu-Baker S
Mol Cell Biol. 2008; 29(1):104-15.
PMID: 18955501
PMC: 2612492.
DOI: 10.1128/MCB.01294-08.
The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer.
Nolan M, Aranda V, Lee S, Lakshmi B, Basu S, Allred D
Cancer Res. 2008; 68(20):8201-9.
PMID: 18922891
PMC: 2948755.
DOI: 10.1158/0008-5472.CAN-07-6567.